About Dr. Palmer
Three decades of internal medicine in Chicago
A Rush-trained internist whose practice has grown out of long relationships — with patients, with colleagues, and with the city he has served since 1989.
Scott Palmer, MD — Internal Medicine, Chicago
Board Certification
Internal Medicine
Residency
Rush University Medical Center — Internal Medicine
Medical School
Rush Medical College
Undergraduate
University of Michigan
Affiliation
Rush University Medical Center
Membership
American Academy of Private Physicians
Biography
Scott Palmer, M.D.
Scott Palmer, M.D., is a board-certified physician in Internal Medicine and a graduate of the University of Michigan and Rush Medical College. Dr. Palmer completed his internship, residency and chief residency at Presbyterian St. Luke's Hospital in Chicago, Illinois — now Rush University Medical Center — receiving the resident of the year award all three years.
He then practiced private internal medicine for twenty-one years at Rush before transitioning to personalized medical care in 2010. Over this time Dr. Palmer has been selected as a "Top Doctors: Chicago Metro Area" by Castle Connolly Medical Ltd., "Top Doctors: Greater Chicago Area" by Consumers' Checkbook, "America's Top Physicians" by Consumers' Research Council of America, "Best Doctors in America" by Best Doctors, Inc., and a "Top Doctor" by U.S. News & World Report.
Dr. Palmer is a member of the American Academy of Private Physicians and has been a Medical Team Physician for both the Chicago Bulls and the Chicago White Sox since 2005.
Affiliated with Rush University Medical Center since 1989, allowing priority referrals to Rush specialists when patients need them.
Medical Team Physician for the Chicago Bulls and Chicago White Sox since 2005.
Honors
Recognized by patients and peers
Research
Work beyond the examining room
Dr. Palmer's research interests center on improving the clinical management of neurodegenerative disorders such as Parkinson's disease, chronic epilepsy and concussion syndromes; discovering new antibiotics to treat multi-drug resistant gram negative bacteria and tuberculosis; improving the management of hypothyroid disorders; developing novel cannabinoids to treat chronic pain and anxiety, chemotherapy-induced nausea, childhood seizures and PTSD; and developing novel immunotherapeutic drugs to treat cancer.
Synthonics, Inc.
Dr. Palmer is Chief Medical Officer and Co-Founder of Synthonics, Inc. In addition to chairing the Synthonics Scientific Advisory Board, he is a member of the Synthonics Board of Directors and medical director of the company's novel drug projects. Synthonics is a global leader in metal coordination pharmaceuticals, with four active U.S. patents and dozens more pending.